For example, we detected sensitivity to HSP90 inhibition in both normal epithelial and cancer cell cultures, corroborating the finding that HSP90 inhibition induces toxicity without tumor‐selective response in patients carrying ALK‐rearranged NSCLC [34, 35]. Here, ALK is linked to non-small cell lung carcinoma.